Summary: Headaches are a common adverse reaction to Rybelsus, affecting between 1 in 10 and 1 in 100 patients taking this oral GLP-1 receptor agonist for type 2 diabetes
Therefore, E4-related bioenergetic dysfunction, such as impairments in FAO of the cerebrovasculature, could have detrimental impacts on its transport functions
Interestingly, semaglutide in combination with BI8271 had a stronger and synergistic effect on weight loss (approximately 33%) and on forelimb grip strength recovery compared with semaglutide monotherapy
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
Dietary intake naturally varies from person to person, particularly for those consuming little or no animal-based foods
Proper injection technique and rotating injection sites can minimize these reactions